The impact of an outpatient palliative care consultation on symptom burden in advanced prostate cancer patients

Sriram Yennurajalingam, Bradley Atkinson, Jessica Masterson, David Hui, Diana Urbauer, Shi Ming Tu, Eduardo Bruera

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Objectives: There are limited studies characterizing cancer-related symptoms in outpatient advanced prostate cancer patients. The aim of this retrospective study was to describe the impact of an outpatient palliative care (PC) consultation on symptoms in patients with advanced prostate cancer. Methods: We retrospectively reviewed the medical records of 55 consecutive patients with advanced prostate cancer seen in our institution's outpatient PC center. Information regarding demographics, disease status, Edmonton Symptom Assessment System (ESAS) scores, Eastern Cooperative Oncology Group (ECOG) Performance Status, laboratory data, and pharmacological interventions were analyzed. Results: The median age of the study's patients was 66 years old, with 73% Caucasian ethnicity. All patients had metastatic disease and 96% had received prior cytotoxic chemotherapy. The most frequently occurring symptoms upon presentation were pain, fatigue, and drowsiness (>50%). Pain and fatigue were also the most severe symptoms, each having median ESAS scores of 7 (on a 0-10 scale). We instituted a median of 3 pharmacological interventions per patient, with a median of 15 days to follow-up assessment. At follow-up, patients reported significant symptom improvements in pain, drowsiness, fatigue, depression, sleep, sense of well-being, and anxiety. Conclusions: Based on our preliminary data, we conclude that patients with advanced prostate cancer referred to PC experience severe and clinically significant symptoms. An outpatient PCconsultation is associated with significant symptom improvement in this subset of a distressed population. Future prospective studies are warranted to further describe symptom burden and the role for outpatient PC for advanced prostate cancer patients.

Original languageEnglish (US)
Pages (from-to)20-24
Number of pages5
JournalJournal of Palliative Medicine
Volume15
Issue number1
DOIs
StatePublished - Jan 1 2012

Fingerprint

Ambulatory Care
Palliative Care
Prostatic Neoplasms
Referral and Consultation
Fatigue
Symptom Assessment
Sleep Stages
Pain
Outpatients
Pharmacology
Medical Records
Sleep
Anxiety
Retrospective Studies
Demography
Prospective Studies
Depression
Drug Therapy

ASJC Scopus subject areas

  • Medicine(all)
  • Anesthesiology and Pain Medicine
  • Nursing(all)

Cite this

Yennurajalingam, S., Atkinson, B., Masterson, J., Hui, D., Urbauer, D., Tu, S. M., & Bruera, E. (2012). The impact of an outpatient palliative care consultation on symptom burden in advanced prostate cancer patients. Journal of Palliative Medicine, 15(1), 20-24. https://doi.org/10.1089/jpm.2011.0219

The impact of an outpatient palliative care consultation on symptom burden in advanced prostate cancer patients. / Yennurajalingam, Sriram; Atkinson, Bradley; Masterson, Jessica; Hui, David; Urbauer, Diana; Tu, Shi Ming; Bruera, Eduardo.

In: Journal of Palliative Medicine, Vol. 15, No. 1, 01.01.2012, p. 20-24.

Research output: Contribution to journalArticle

Yennurajalingam, S, Atkinson, B, Masterson, J, Hui, D, Urbauer, D, Tu, SM & Bruera, E 2012, 'The impact of an outpatient palliative care consultation on symptom burden in advanced prostate cancer patients', Journal of Palliative Medicine, vol. 15, no. 1, pp. 20-24. https://doi.org/10.1089/jpm.2011.0219
Yennurajalingam, Sriram ; Atkinson, Bradley ; Masterson, Jessica ; Hui, David ; Urbauer, Diana ; Tu, Shi Ming ; Bruera, Eduardo. / The impact of an outpatient palliative care consultation on symptom burden in advanced prostate cancer patients. In: Journal of Palliative Medicine. 2012 ; Vol. 15, No. 1. pp. 20-24.
@article{5fc351f4ba6f44fb9ca1d25fd5304507,
title = "The impact of an outpatient palliative care consultation on symptom burden in advanced prostate cancer patients",
abstract = "Objectives: There are limited studies characterizing cancer-related symptoms in outpatient advanced prostate cancer patients. The aim of this retrospective study was to describe the impact of an outpatient palliative care (PC) consultation on symptoms in patients with advanced prostate cancer. Methods: We retrospectively reviewed the medical records of 55 consecutive patients with advanced prostate cancer seen in our institution's outpatient PC center. Information regarding demographics, disease status, Edmonton Symptom Assessment System (ESAS) scores, Eastern Cooperative Oncology Group (ECOG) Performance Status, laboratory data, and pharmacological interventions were analyzed. Results: The median age of the study's patients was 66 years old, with 73{\%} Caucasian ethnicity. All patients had metastatic disease and 96{\%} had received prior cytotoxic chemotherapy. The most frequently occurring symptoms upon presentation were pain, fatigue, and drowsiness (>50{\%}). Pain and fatigue were also the most severe symptoms, each having median ESAS scores of 7 (on a 0-10 scale). We instituted a median of 3 pharmacological interventions per patient, with a median of 15 days to follow-up assessment. At follow-up, patients reported significant symptom improvements in pain, drowsiness, fatigue, depression, sleep, sense of well-being, and anxiety. Conclusions: Based on our preliminary data, we conclude that patients with advanced prostate cancer referred to PC experience severe and clinically significant symptoms. An outpatient PCconsultation is associated with significant symptom improvement in this subset of a distressed population. Future prospective studies are warranted to further describe symptom burden and the role for outpatient PC for advanced prostate cancer patients.",
author = "Sriram Yennurajalingam and Bradley Atkinson and Jessica Masterson and David Hui and Diana Urbauer and Tu, {Shi Ming} and Eduardo Bruera",
year = "2012",
month = "1",
day = "1",
doi = "10.1089/jpm.2011.0219",
language = "English (US)",
volume = "15",
pages = "20--24",
journal = "Journal of Palliative Medicine",
issn = "1096-6218",
publisher = "Mary Ann Liebert Inc.",
number = "1",

}

TY - JOUR

T1 - The impact of an outpatient palliative care consultation on symptom burden in advanced prostate cancer patients

AU - Yennurajalingam, Sriram

AU - Atkinson, Bradley

AU - Masterson, Jessica

AU - Hui, David

AU - Urbauer, Diana

AU - Tu, Shi Ming

AU - Bruera, Eduardo

PY - 2012/1/1

Y1 - 2012/1/1

N2 - Objectives: There are limited studies characterizing cancer-related symptoms in outpatient advanced prostate cancer patients. The aim of this retrospective study was to describe the impact of an outpatient palliative care (PC) consultation on symptoms in patients with advanced prostate cancer. Methods: We retrospectively reviewed the medical records of 55 consecutive patients with advanced prostate cancer seen in our institution's outpatient PC center. Information regarding demographics, disease status, Edmonton Symptom Assessment System (ESAS) scores, Eastern Cooperative Oncology Group (ECOG) Performance Status, laboratory data, and pharmacological interventions were analyzed. Results: The median age of the study's patients was 66 years old, with 73% Caucasian ethnicity. All patients had metastatic disease and 96% had received prior cytotoxic chemotherapy. The most frequently occurring symptoms upon presentation were pain, fatigue, and drowsiness (>50%). Pain and fatigue were also the most severe symptoms, each having median ESAS scores of 7 (on a 0-10 scale). We instituted a median of 3 pharmacological interventions per patient, with a median of 15 days to follow-up assessment. At follow-up, patients reported significant symptom improvements in pain, drowsiness, fatigue, depression, sleep, sense of well-being, and anxiety. Conclusions: Based on our preliminary data, we conclude that patients with advanced prostate cancer referred to PC experience severe and clinically significant symptoms. An outpatient PCconsultation is associated with significant symptom improvement in this subset of a distressed population. Future prospective studies are warranted to further describe symptom burden and the role for outpatient PC for advanced prostate cancer patients.

AB - Objectives: There are limited studies characterizing cancer-related symptoms in outpatient advanced prostate cancer patients. The aim of this retrospective study was to describe the impact of an outpatient palliative care (PC) consultation on symptoms in patients with advanced prostate cancer. Methods: We retrospectively reviewed the medical records of 55 consecutive patients with advanced prostate cancer seen in our institution's outpatient PC center. Information regarding demographics, disease status, Edmonton Symptom Assessment System (ESAS) scores, Eastern Cooperative Oncology Group (ECOG) Performance Status, laboratory data, and pharmacological interventions were analyzed. Results: The median age of the study's patients was 66 years old, with 73% Caucasian ethnicity. All patients had metastatic disease and 96% had received prior cytotoxic chemotherapy. The most frequently occurring symptoms upon presentation were pain, fatigue, and drowsiness (>50%). Pain and fatigue were also the most severe symptoms, each having median ESAS scores of 7 (on a 0-10 scale). We instituted a median of 3 pharmacological interventions per patient, with a median of 15 days to follow-up assessment. At follow-up, patients reported significant symptom improvements in pain, drowsiness, fatigue, depression, sleep, sense of well-being, and anxiety. Conclusions: Based on our preliminary data, we conclude that patients with advanced prostate cancer referred to PC experience severe and clinically significant symptoms. An outpatient PCconsultation is associated with significant symptom improvement in this subset of a distressed population. Future prospective studies are warranted to further describe symptom burden and the role for outpatient PC for advanced prostate cancer patients.

UR - http://www.scopus.com/inward/record.url?scp=84856241418&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84856241418&partnerID=8YFLogxK

U2 - 10.1089/jpm.2011.0219

DO - 10.1089/jpm.2011.0219

M3 - Article

C2 - 22141432

AN - SCOPUS:84856241418

VL - 15

SP - 20

EP - 24

JO - Journal of Palliative Medicine

JF - Journal of Palliative Medicine

SN - 1096-6218

IS - 1

ER -